WHAT’S NEXT FOR POST-ACUTE MARKETS?
Convalescing From COVID: The Road Ahead For Post-Acute Providers
COVID-19 has been especially brutal for nursing homes. People in long-term care facilities have accounted for less than 10% of all coronavirus cases but 45% of COVID-19 deaths – 70,000 patients and staff as of mid-August. Find out what it will take for nursing facilities to recover, and what the industry may look like when the pandemic is over.
- How nursing homes can weather the negative financial impacts of COVID-19
- What types of providers are most at risk
- How their business partners can help
How The COVID Experience Will Change Post-Acute Providers’ Supply Chain Strategies
Most nursing homes and other long-term care facilities had fairly simple supply chain needs and structures prior to the pandemic – many didn’t even have so much as a purchasing agent. COVID-19 hit hard, and these facilities needed PPE and other products they’d never used before and couldn’t easily acquire. In this session, consider:
- How the supply chain will reorganize to better serve post-acute providers
- What manufacturers and distributors can do to best support this market
- Where the greatest challenges and opportunities lie
The Future For Home Health And Hospice
Three months into the pandemic, 90% of home health agencies reported a decline in admissions and revenue. Some clients paused services because family members were able to provide care while working from home; others refused to allow caregivers into the home for risk of exposure. Many hospice organizations were similar affected.
- Understand how well and how quickly home health and hospice providers are recovering
- Find out how their menu of services is evolving to better support current customer concerns and needs
- Discuss the role of supply chain partners in home care’s post-pandemic success
WHAT’S NEXT FOR LAB AND DIAGNOSTICS?
COVID Testing: What’s Happening Now, And What’s Ahead
Since the pandemic began, the diagnostics industry has been overwhelmingly focused on development and distribution of Covid tests: faster PCR products, more accurate antigen tests, and more meaningful antibody assays. In this session, explore what’s next:
- Demand for COVID testing as vaccination expands
- The growing role of antibody tests
- Key questions from providers as they navigate changing diagnostics requirements
Elevating Diagnostics in the Post-COVID Healthcare Environment
Robert Michel, Editor-in-Chief,
DARK Daily and the Dark Report
A year ago, lab testing was the behind-the-scene factor driving the vast majority of medical decisions. As the pandemic progressed, diagnostics moved front-and-center, with policymakers, media, and consumers discussing the merits of different methodologies and the importance of expanded testing.
- How can the diagnostics industry leverage its greatly increased visibility?
- How might the COVID experience impact product approvals, reimbursement, and other key policy decisions in the future?
Trends in Diagnostics Distribution
Diagnostics manufacturers depend on a strong partnership with distributors to create demand, educate providers, and deliver products to lab customers nationwide. Take part in this candid discussion with lab distributors for insights on:
- Where testing will be delivered, and how to best reach those market segments
- What policy and payment rules are currently driving opportunities for diagnostics growth
- How to build sales and marketing support from your supply chain partners